- The trend backdrop is active with a 29-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
JNJ
EBS
Week ended 07 Aug 2026
Weekly Investor Report
JOHNSON&JOHNSON · Healthcare · Drug Manufacturers - General
Latest close
207.4 CHF
0.0%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 10.8% above the Trend Line and sits at 85.7% of its 52-week range. The latest completed week returned 0.0%, after a -0.7% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
58
out of 100
Latest Close
207.4 CHF
7 Aug 2026
1W Return
0.0%
latest completed week
4W Return
-0.7%
short-term follow-through
12W Return
18.0%
quarterly tape
Trend Breadth
86.5%
45 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- Next-week expectancy is negative at 36.15% based on similar historical setup states.
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move -0.7%.
Indicator stack
93/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.15%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 10.8% above the Trend Line and sits at 85.7% of its 52-week range. The latest completed week returned 0.0%, after a -0.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7012-week average 0.65
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.7% over four weeks, 18.0% over 12 weeks, and 47.2% over one year. The current trend has remained active for 29 consecutive weeks.
Performance by holding period
Active trend streak29 weeks
Active weeks in one year45
Trend breadth86.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.69Latest activity-pressure read.
Pressure change224.8%Four-week change in activity pressure.
Leadership4.11Latest relative-leadership reading.
RS change-45.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.7%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+10.5%Week of 26 Jun.
Worst week-3.9%Week of 8 May.
Latest week+0.0%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains14
Flat weeks0
Modest losses10
Sharp losses0
Recent vol3.6%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split22/11Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank24 / 40
Group average2.0%
Trend breadth52.5%
Trend52.5%active weekly trend signals
MD62.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryCH Drug Manufacturers - General
4-week rank4 / 6
Group average2.3%
Trend breadth83.3%
Trend83.3%active weekly trend signals
MD83.3%positive activity pressure
RS83.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape60/100
Trend, activity pressure, participation, and risk combine to a 60/100 tape read.
Indicator analysis67/100Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 9/12.
Activity pressure 0.70; 2 reversal markers Next-Week ExpectancyNegative 36.15%Next-week expectancy is negative with a 36.15% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Johnson & Johnson (JNJ) Stock Looks Cheap On Cash Flow Yet Pricey On Earnings Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 207.4 CHF | 0.0% | 187.2 CHF | 155.2 CHF | 0.69 | 4.11 | 1 | On |
| 31 Jul 2026 | 207.3 CHF | -3.2% | 184.9 CHF | 154.7 CHF | 0.67 | 5.53 | 0 | On |
| 24 Jul 2026 | 214.1 CHF | 4.5% | 182.6 CHF | 154.1 CHF | 0.62 | 9.21 | 0 | On |
| 17 Jul 2026 | 204.8 CHF | -2.0% | 180.1 CHF | 153.4 CHF | 0.45 | 4.53 | 0 | On |
| 10 Jul 2026 | 208.9 CHF | 0.1% | 177.9 CHF | 152.9 CHF | 0.21 | 7.54 | 0 | On |
| 3 Jul 2026 | 208.7 CHF | 2.5% | 175.5 CHF | 152.2 CHF | 0.01 | 6.16 | 0 | On |
| 26 Jun 2026 | 203.6 CHF | 10.5% | 173.1 CHF | 151.6 CHF | -0.22 | 5.59 | 0 | On |
| 19 Jun 2026 | 184.3 CHF | -3.4% | 170.9 CHF | 151.0 CHF | -0.37 | -1.53 | 0 | On |
| 12 Jun 2026 | 190.9 CHF | 3.5% | 169.3 CHF | 150.6 CHF | -0.40 | 2.38 | 0 | On |
| 5 Jun 2026 | 184.4 CHF | 1.9% | 168.2 CHF | 150.2 CHF | -0.52 | 1.30 | 0 | On |
| 29 May 2026 | 181.0 CHF | -0.4% | 167.2 CHF | 149.8 CHF | -0.57 | -1.69 | 48 | On |
| 22 May 2026 | 181.7 CHF | 3.4% | 166.4 CHF | 149.4 CHF | -0.61 | -1.10 | 0 | On |
| 15 May 2026 | 175.8 CHF | 2.2% | 165.1 CHF | 149.0 CHF | -0.53 | -2.33 | 0 | On |
| 8 May 2026 | 171.9 CHF | -3.9% | 164.0 CHF | 148.7 CHF | -0.27 | -3.70 | 0 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.